Biomarkers to finetune depression treatment

November 8, 2013 by Rogini Moorthi
Biomarkers to finetune depression treatment
"By assessing blood samples, we can look for these markers to treat inflammation and oxidative stress"— Mr Lopresti. Credit: jaubelle1

The use of inflammatory and oxidative stress biomarkers in psychiatry may have the potential to improve treatment efficacy and aid in the diagnosis of major depression, a review has found.

Major depression is a with current treatment remission rates reaching 20–40 per cent.

Currently, the assessment and treatment of depression is carried out through a combination of patient interviews, self-reports and questionnaires.

Murdoch University PhD student and clinical psychologist Adrian Lopresti reviewed existing studies outlining the potential of inflammatory and oxidative peripheral in aiding diagnosis, predicting treatment response, and preventing the onset of .

Mr Lopresti says the researchers reviewed biomarkers because the area is gaining momentum in depression studies.

"Over the last 10 years, researchers have also found that depression is associated with high levels of inflammation and free radical damage," he says.

"When the body is inflamed, there is an imbalance in the levels of serotonin – a neurotransmitter in the brain – which may influence mood in a way that leads to depression.

"Thus, by assessing blood samples, we can look for these markers to treat inflammation and oxidative stress."

Mr Lopresti says biomarkers could potentially help guide clinicians in choosing the right treatment for depressed individuals.

"For instance, there was one study in which an anti-inflammatory drug [infliximab] was administered to patients with major depression and when the group was examined as a whole, researchers found the infliximab drug did not work," he says.

"However, when a sub-group of the depressed patients with high levels of inflammation were examined, the researchers found that the anti-inflammatory drug worked for them."

He says biomarkers could determine if people with high levels of have a greater chance of developing depression five years later.

"Although this is an area that requires greater research, we believe that these inflammatory and oxidative stress biomarkers can help with the diagnosis, treatment matching, and potentially the prevention of depression."

However, for clinicians to be able to use biomarkers and learn more about them, Mr Lopresti says there has to be greater consistencies across research.

"Typically, blood, urine and saliva samples are collected in research studies; and within blood collections, serum and whole blood are used for biomarker measurement resulting in variations in the specimens utilised to make comparisons.

"We are hoping that in the next 10 years, when there is more consistency in the research we can introduce biomarkers into clinical practice."

Explore further: Targeting inflammation to treat depression

More information: www.sciencedirect.com/science/article/pii/S0278584613002121

Related Stories

Targeting inflammation to treat depression

September 3, 2012

Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of ...

Biomarkers for antidepressant treatment response

September 20, 2012

(Medical Xpress)—Researchers from King's College London's Institute of Psychiatry (IoP) have identified new biomarkers for antidepressant treatment response, an important step towards developing personalised treatments ...

Brain inflammation linked to more severe Parkinson's symptoms

August 28, 2013

Reversing inflammation in the fluid surrounding the brain's cortex may provide a solution to the complex riddle of Parkinson's, according to researchers who have found a link between pro-inflammatory biomarkers and the severity ...

Depression may increase your risk of Parkinson's disease

October 2, 2013

People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

Recommended for you

Half of people believe fake facts

December 7, 2016

Many people are prone to 'remembering' events that never happened, according to new research by the University of Warwick.

MRI scans detect 'brain rust' in schizophrenia

December 7, 2016

A damaging chemical imbalance in the brain may contribute to schizophrenia, according to research presented at the American College of Neuropsychopharmacology Annual Meeting in Hollywood, Florida.

Helping children achieve more in school

December 7, 2016

Not all children do well in school, despite being intellectually capable. Whilst parental relationships, motivation and self-concept all have a role to play, a recent study published in the journal Frontiers in Psychology ...

Want to give a good gift? Think past the 'big reveal'

December 6, 2016

Gift givers often make critical errors in gift selection during the holiday season, according to a new research article in Current Directions in Psychological Science, a journal of the Association for Psychological Science.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.